Acute orbital inflammation

Summary

Acute orbital inflammation (MONDO:0001230) is a disease. A subtype of disease of orbital part of eye adnexa — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	acute orbital inflammation
Mondo ID	MONDO:0001230
DOID	DOID:11230
ICD-10-CM	H05.0
ICD-11	1830014336
SNOMED CT	20551005
UMLS	C0155256
MedGen	509876
Is cancer (heuristic)	no

Also known as: acute inflammation of orbit

Disease family

This is a subtype of disease of orbital part of eye adnexa. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › disease of orbital part of eye adnexa › acute orbital inflammation

Related subtypes (8): enophthalmos, endocrine exophthalmos, lateral displacement of eye, intermittent proptosis, pulsating exophthalmos, chronic orbital inflammation, orbital cyst, constant exophthalmos

Subtypes (4): orbital periostitis, orbital osteomyelitis, orbital tenonitis, orbital cellulitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.